.svg){kind=icon}
.svg){kind=icon}
.png)
.svg){kind=icon}
.svg){kind=icon}
Extended Stability for Parenteral Drugs
Extended stability and compatibility data for injectables
.jpg)
Title Details
© 2026, American Society of Health-System Pharmacists, Inc.
Pharmacy/Pharmacology
Additional Details
Get the support you need to safely extend dating of parenteral drugs beyond the usual 24-hour limit—minimizing waste, lowering medication costs, and enabling optimal patient administration schedules at alternate infusion sites. Features the inclusion of monographs expanded beyond home infusion to be inclusive of all clinical settings where parenteral drugs are stored or compounded.
Extended Stability for Parenteral Drugs, covers all aspects of determining stability, including the changing elastomeric landscape and the ongoing variability in stability data.
Core Benefits
- Reduces Waste: Minimizes discarded medication by safely validating longer use times.
- Lowers Costs: Decreases overall drug expenditures for facilities and patients.
- Improves Schedules: Enables better patient administration timelines, particularly in outpatient and alternate-site settings.
What's the Included
- Expanded Settings: Includes monographs for all clinical environments where drugs are stored or compounded, moving beyond just home infusion.
- Stability Factors: Addresses changes in container materials (elastomeric landscape) and variations in physical or chemical stability data.
- Specialized Data: Features updated guidance on oncology, specialty, parenteral nutrition, and COVID-19 medications.
Similar Resources
Trusted References. AI-Assisted Search.
Available with a STAT!Ref subscription, STAT!Ref AI searches your licensed content and provides answers with links to sources. Connect with our team to build your institution’s collection and explore AI-assisted search.
